EVCM vs DBD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

EVCM

42.4
AI Score
VS
EVCM Wins

DBD

36.2
AI Score

Investment Advisor Scores

EVCM

42score
Recommendation
HOLD

DBD

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric EVCM DBD Winner
Revenue 299.48M 1.82B DBD
Net Income 16.89M 20.50M DBD
Net Margin 5.6% 1.1% EVCM
Operating Income 30.05M 90.00M DBD
ROE 2.4% 2.1% EVCM
ROA 1.2% 0.5% EVCM
Total Assets 1.36B 3.74B DBD
Debt/Equity 0.73 0.97 EVCM
Current Ratio 2.14 1.27 EVCM

Relative Price Performance (Last 90 Days)

EVCM 1M: +14.6% · 3M: -16.5% DBD 1M: +5.9% · 3M: -21.6%

Current Technical Phase

EVCM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.8 · Price: $9.24

DBD

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 60

RSI (14): 60.3 · Price: $68.16

Fundamentals Snapshot

Metric EVCM DBD
Market Cap — —
Forward P/E 11.7 9.7
Trailing P/E 61.1 22.4
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.8% 0.3%
Operating Margin 0.1% 0.1%
EPS 0.15 3.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, EVCM is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.